Table 2.
First Author | Year | Prediction Form | Number of Patients | Prognosticators | Prediction of | Accuracy | Validation |
---|---|---|---|---|---|---|---|
Brien [108] | 2010 | Risk group stratification | 172 | Hydronephrosis, biopsy grade and urinary cytology |
NOC UTUC Muscle Invasive |
PPV 73 NPV 100 PPV 89 NPV 100 |
|
Margulis [109] | 2010 | Nomogram | 659 | Tumor architecture, tumor grade and tumor location |
NOC UTUC | 76.6 | Internal |
Favaretto [91] | 2012 | Risk group stratification | 274 | Ureteroscopic grade, tumor location, Hydronephrosis and invasion on imaging | NOC Muscle Invasive |
70 71 |
|
Chen [110] | 2013 | Nomogram | 693 | Gender, architecture, multifocality, tumor location, grade and Hydronephrosis |
NOC Muscle Invasive |
79 79 |
Internal |
Petros [92] | 2018 | Nomogram | 566 | Ureteroscopic grade, Architecture, Hemoglobin, Clinical stage | NOC UTUC | 82 Development 77 Validation |
Internal & External |
Yoshida [111] | 2020 | Nomogram | 1101 | NLR, CKD, Tumor location, Hydronephrosis, Local invasion on imaging | NOC UTUC | 77 | Internal & External |
Foerster [49] | 2021 | Nomogram | 1214 | Previous RC, architecture, multifocality, invasion on imaging, tumor size, Preoperative hydronephrosis, Cytology, Biopsy staging, biopsy grading, sex, age | ≥pT2/N+ | 75 (bias corrected) | Internal |
Marcq [47] | 2022 | Risk group stratification | 1214 | ≥cT3, sessile architecture, hydronephrosis, High grade cytology, high grade biopsy, age at Dx | ≥pT2 | 77 | |
Venkat [46] | 2022 | Nomogram | 6143 | Age, architecture, urine cytology, biopsy grade, LVI, Tumor size, cN | ≥pT2 | 80 | Internal |
Venkat [46] | 2022 | Nomogram | 6143 | LVI, cN, Biopsy grade, tumor size | Positive Node | 87.8 | Internal |
NOC: Non-organ confined; PPV: Positive predictive value; NPV: Negative predictive value; NLR: Neutrophil to lymphocyte ratio; CKD: Chronic kidney disease; RC: Radical cystectomy; Dx: Diagnosis; cN: clinical Node-positive.